STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)		1 Months Ended	3 Months Ended
	Sep. 02, 2022	Nov. 30, 2022	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Subsidiary, Sale of Stock [Line Items]
Stock issued for services, value			$ 76,000	$ 107,000
Proceeds from Issuance of Common Stock			158,000	0
Unrecognized compensation costs			$ 1,200,000
Number of stock options vested			267,975
Number of stock options unvested			11,899		17,865
Unrecognized restricted stock grant expense			1 year 9 months
Warrants price per share			$ 8.05
Equity Option [Member]
Subsidiary, Sale of Stock [Line Items]
Stock compensation expense			$ 100,000	100,000
Cost Not yet Recognized, Period for Recognition			3 years 8 months 12 days
Intrinsic value of options outstanding			$ 2,000,000
Intrinsic value of options exercised outstanding			$ 1,700,000
Number of stock options unvested			69,296
Restricted Stock Units (RSUs) [Member]
Subsidiary, Sale of Stock [Line Items]
Cost Not yet Recognized, Period for Recognition			1 year 10 months 24 days
Stock units outstanding			71,250
Weighted average grant date fair values			$ 13.05
Cost has not been recognized			$ 2,300,000
Performance Stock Units [Member]
Subsidiary, Sale of Stock [Line Items]
Stock units outstanding			142,500
Weighted average grant date fair values			$ 13.05
RSUs and PSUs [Member]
Subsidiary, Sale of Stock [Line Items]
Stock compensation expense			$ 300,000
Restricted Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Stock compensation expense				$ 100,000
Restricted Stock Grants [Member]
Subsidiary, Sale of Stock [Line Items]
Cost has not been recognized			$ 200,000
Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Cost Not yet Recognized, Period for Recognition			5 years
Cost has not been recognized			$ 1,600,000
Company issued warrants to purchase Common stock			200,000
Fair value of warrants			$ 1,600,000
Risk free market interest rate			3.86%
Expected dividend yield			0.00%
Expected life			2 years 6 months
Expected volatility rate			99.60%
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms			1 year 18 days
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding			$ 4,100,000
Chief Executive Officer [Member] | Restricted Stock Units (RSUs) [Member]
Subsidiary, Sale of Stock [Line Items]
Restricted stock units granted		142,500
Chief Executive Officer [Member] | Performance Stock Units [Member]
Subsidiary, Sale of Stock [Line Items]
Restricted stock units granted		142,500
B Riley Purchase Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Stock Issued During Period, Shares, New Issues			37,741
Proceeds from Issuance of Common Stock			$ 700,000
Payments of Stock Issuance Costs			$ 500,000
B Riley Purchase Agreement [Member] | B Riley Capital [Member]
Subsidiary, Sale of Stock [Line Items]
Stock Issued During Period, Shares, New Issues	10,484
Marketing Services [Member]
Subsidiary, Sale of Stock [Line Items]
Stock issued for services, shares			6,444
Stock issued for services, value			$ 100,000